These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24567134)

  • 1. Microfluidic-based manufacture of siRNA-lipid nanoparticles for therapeutic applications.
    Walsh C; Ou K; Belliveau NM; Leaver TJ; Wild AW; Huft J; Lin PJ; Chen S; Leung AK; Lee JB; Hansen CL; Taylor RJ; Ramsay EC; Cullis PR
    Methods Mol Biol; 2014; 1141():109-20. PubMed ID: 24567134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery.
    Kimura N; Maeki M; Sato Y; Ishida A; Tani H; Harashima H; Tokeshi M
    ACS Appl Mater Interfaces; 2020 Jul; 12(30):34011-34020. PubMed ID: 32667806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems.
    Leung AK; Tam YY; Chen S; Hafez IM; Cullis PR
    J Phys Chem B; 2015 Jul; 119(28):8698-706. PubMed ID: 26087393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an Alcohol Dilution-Lyophilization Method for Preparing Lipid Nanoparticles Containing Encapsulated siRNA.
    Shirane D; Tanaka H; Nakai Y; Yoshioka H; Akita H
    Biol Pharm Bull; 2018; 41(8):1291-1294. PubMed ID: 30068880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA.
    Kulkarni JA; Darjuan MM; Mercer JE; Chen S; van der Meel R; Thewalt JL; Tam YYC; Cullis PR
    ACS Nano; 2018 May; 12(5):4787-4795. PubMed ID: 29614232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the role of helper lipids in lipid nanoparticle formulations of siRNA.
    Kulkarni JA; Witzigmann D; Leung J; Tam YYC; Cullis PR
    Nanoscale; 2019 Nov; 11(45):21733-21739. PubMed ID: 31713568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Size and Charge of Lipid Nanoparticles Prepared by Microfluidic Mixing on Their Lymph Node Transitivity and Distribution.
    Nakamura T; Kawai M; Sato Y; Maeki M; Tokeshi M; Harashima H
    Mol Pharm; 2020 Mar; 17(3):944-953. PubMed ID: 31990567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of Peptidomimetic Functionalized Cholesterol Based Lipid Nanoparticles for Efficient Delivery of Therapeutic Nucleic Acids.
    Ehexige E; Ganbold T; Yu X; Han S; Baigude H
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31546908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer-lipid hybrid nanoparticles as enhanced indomethacin delivery systems.
    Dalmoro A; Bochicchio S; Nasibullin SF; Bertoncin P; Lamberti G; Barba AA; Moustafine RI
    Eur J Pharm Sci; 2018 Aug; 121():16-28. PubMed ID: 29777855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the heterogeneity level in lipid nanoparticles for siRNA delivery: size-based separation, compositional heterogeneity, and impact on bioperformance.
    Zhang J; Pei Y; Zhang H; Wang L; Arrington L; Zhang Y; Glass A; Leone AM
    Mol Pharm; 2013 Jan; 10(1):397-405. PubMed ID: 23210488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of cholesterol-conjugated ionizable amino lipids with biomembranes: lipid polymorphism, structure-activity relationship, and implications for siRNA delivery.
    Zhang J; Fan H; Levorse DA; Crocker LS
    Langmuir; 2011 Aug; 27(15):9473-83. PubMed ID: 21648950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-Step Production Using a Microfluidic Device of Highly Biocompatible Size-Controlled Noncationic Exosome-like Nanoparticles for RNA Delivery.
    Kimura N; Maeki M; Ishida A; Tani H; Tokeshi M
    ACS Appl Bio Mater; 2021 Feb; 4(2):1783-1793. PubMed ID: 35014524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfluidic-controlled manufacture of liposomes for the solubilisation of a poorly water soluble drug.
    Kastner E; Verma V; Lowry D; Perrie Y
    Int J Pharm; 2015 May; 485(1-2):122-30. PubMed ID: 25725309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of an Efficient Microfluidic Mixing System for Generating Stabilized Polymeric Nanoparticles for Controlled Drug Release.
    Morikawa Y; Tagami T; Hoshikawa A; Ozeki T
    Biol Pharm Bull; 2018; 41(6):899-907. PubMed ID: 29863078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical characterization techniques for lipid based delivery systems for siRNA.
    Kapoor M; Burgess DJ; Patil SD
    Int J Pharm; 2012 May; 427(1):35-57. PubMed ID: 21979250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation.
    Chen D; Love KT; Chen Y; Eltoukhy AA; Kastrup C; Sahay G; Jeon A; Dong Y; Whitehead KA; Anderson DG
    J Am Chem Soc; 2012 Apr; 134(16):6948-51. PubMed ID: 22475086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA.
    Belliveau NM; Huft J; Lin PJ; Chen S; Leung AK; Leaver TJ; Wild AW; Lee JB; Taylor RJ; Tam YK; Hansen CL; Cullis PR
    Mol Ther Nucleic Acids; 2012 Aug; 1(8):e37. PubMed ID: 23344179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography.
    Zhang J; Haas RM; Leone AM
    Anal Chem; 2012 Jul; 84(14):6088-96. PubMed ID: 22816783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of Polymer-Lipid Nanoparticles by Microfluidic Focusing for siRNA Delivery.
    Li Y; Huang X; Lee RJ; Qi Y; Wang K; Hao F; Zhang Y; Lu J; Meng Q; Li S; Xie J; Teng L
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27763492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Microfluidics for the Preparation of Drug and Gene Delivery Systems.
    Tomeh MA; Zhao X
    Mol Pharm; 2020 Dec; 17(12):4421-4434. PubMed ID: 33213144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.